2.Determination of Correlative Immunomolecules in Peripheral Blood From 16 Patients With Leprosy
Baoquan ZHAO ; Geping YIN ; Junxiang LU
Journal of Chinese Physician 2001;0(07):-
Objective To investigate the relationship between leprosy and some correlative immunomolecules in peripheral blood.Methods lymphocytes from peripheral blood in 16 leprosy patients in different periods were immunologically labeled by monoclonal antibodies from mouse CD 3/CD 4/CD 8,CD 3/CD (16+56) (NK) and CD 3/HLA-DR were determined by using flow cytometry(FCM).Results The levels of CD 3 +/CD 4 +,CD 3 +/HLA-DR and CD 4/CD 8 ratio in active period were lower in 16 patients than those of normal group,while CD 3 +/CD (16+56) +,CD 3 +/HLA-DR + were higher,NK was in the normal range.In stable period 2~4 week after treatment CD 3 +/CD 4 +,CD 3/HLA-DR - and CD 4/CD 8 were gradually increased,CD 3 +/CD (16+56) +,CD 3 +/CD 8 + and CD 3 +/HLA-DR + were increased slightly or no change ,and NK was increased slightly in 13 cases in unstable period.In other 3 case,CD 3 +/CD 4 +,CD 3 +/HLA-DR and CD 4/CD 8 were decreased than that in stable period,while the CD 3 +/CD (16+56) +,CD 3 +/HLA-DR + and NK were double increased than that in stable period.Conclusions Dynamic determination of associated immunlogical molecules in peripheral blood of leprosy patients is helpful to evaluate the change of illness state,it also play an important role in the treatmant of the disease.
3.Identification study of Mongolian drug Xingqizhitong Pills
Minggan BAI ; Baishui ZHAO ; Baoquan BAO ;
Chinese Traditional Patent Medicine 1992;0(06):-
Objective: To establish an identification for Xingqizhitong Pills Methods: The microscopical identification and TLC were used. Results: Semen strychni, Radix aucklandiae, Flos carthami, Fructus chebulae, Lignum aquilariae resinatum could be detected out by TLC. Also Gypsum fibrosum and Resina liquidambaris were identified by physical and chemical identification. Conclusion:The experimental method is simple, reproducible and accurate.
4.SelectivePosteriorRhizotomyfortheTreatmentofCerebralPalsy
Meicai QIN ; Shenmao DING ; Baoquan ZHAO ; ETAL
Chinese Journal of Orthopaedics 1996;0(10):-
FromFebruary1992toJune1995,selectiveposteriorrhizotomy(SPR)wasperformedin12patientswithspasticityoftheupperlimbsresultedfromcerebralpalsy.Posteriorcervicalnerveroots,fromC5toT1wereseveredinproportionsof40%,50%,60%,50%and35%oftheC5,C6,C7,C8andT1respectively.Abnormalhighmusculartensionintheupperlimbswasfoundtobeefec-tivelyrelievedduringthefolow-up.Thisprocedureisregardedasasatisfactorymethodforrelievingthespasticityoftheupperlimbs.
5.Zebrafish as a model animal for the study of blood-brain barrier permeability by biomolecules.
Ailing FU ; Hengyu CHEN ; Xingran XU ; Baoquan ZHAO
Acta Pharmaceutica Sinica 2012;47(11):1447-51
Blood-brain barrier (BBB) is the major obstacle for drug delivery into the central nervous system (CNS). However, there is no ideal model animal for the study of BBB permeability till now. Currently zebrafish (Danio rerio) has emerged as a powerful model organism for the study of vertebrate biology. In this study, the feasibility of using zebrafish as model animal was investigated for BBB permeability by comparing the results of administration of BBB-penetrating peptide and protein to mouse and zebrafish. The results showed that the BBBs of mouse and zebrafish were similar in molecular permeability. Additionally, zebrafish has advantageous features as a model animal, such as small size, fertile and easy to breed. Therefore, it is suggested that zebrafish may be a favored model for the study of BBB permeability.
6.EXPRESSION OF VEGF-C AND VEGFR-3 IN RAT COLORECTAL CANCER INDUCED BY MNNG
Shucai YANG ; Jing MA ; Baoquan LIU ; Linghua ZHAO ; Yafang ZHANG
Acta Anatomica Sinica 1953;0(01):-
Objective To investigate the expression of vascular endothelial growth factor C(VEGF-C) and vascular endothelial growth factor receptor-3(VEGFR-3) in rat colorectal cancer,and to provide an experimental material for the role of VEGF-C and its receptor VEGFR-3 in cancer progression and metastasis via lymphatics. Methods The expressions of VEGF-C and its receptor VEGFR-3 in colorectal cancer induced by MNNG were observed by immunohistochemistry staining. Results There was no expression of VEGF-C in normal colorectal tissues,but VEGFR-3 expressed in the lymphatic endothelium.The protein of VEGF-C mainly expressed in the cancer cells and the positive rates were 75% and 100% respectively in the early and the mid-terminal stages of cancer.The positive expression of VEGF-C in the early stage of cancer was higher than that in mid-terminal stage(P
7.Treatment of 32 patients with severe thoracic and abdominal injury accompanied with acute respiratory distress syndrome
Weijian WENG ; Jianrong SI ; Baoquan JIA ; Yuyuan ZHAO ; Daoxin LEI ;
Chinese Journal of Emergency Medicine 2006;0(09):-
Objective To study an effective treatment of severe thoracic and abdominal injury accompanied with acute respiratory distress syndromes (ARDS).Methods Emergency treatments of 32 patients with severe thoracic and abdominal trauma accompanied with ARDS were retrospectively analyzed.Results All of the 32 patients had severe thoracic and abdominal injury,ribs fracture or pulmonary contuson.Anti-shock treatment,reasonable supplemental blood volume,rational mechanical ventilation and emergency operation were performed.Twenty-six patients were cured,and 6 died,with mortality 18.75%.Conclusions Early diagnosis,timely anti-shock treatment,early treatment for thoracic and abdominal injury and correct mechanical ventilation are essential for treating thoracic and abdominal trauma accompanied by ARDS,and is also an effective method for reducing mortality.
8.EXPRESSION OF VEGFR-3 IN LYMPHATIC ENDOTHELIUM OF THE SKIN IN RAT EMBRYOS
Jing MA ; Linghui ZHAO ; Baoquan LIU ; Yafang ZHANG ; Shucai YANG
Acta Anatomica Sinica 2002;0(05):-
Objective To analyse the expression patterns of the vascular endothelial growth factor receptor 3(VEGFR-3) at the protein and mRNA level,and to detect the biological function of VEGFR-3 in the lymphangiogenesis of the embryos. Methods A total of 61 specimens of skin were investigated by immunohistochemical staining with a polyclonal antibody against VEGFR-3 in embryo 15-day-old(E15) and in embryo 21-day-old(E21).The expression of VEGFR-3 mRNA was studied in situ hybridization. Results The positive expression of VEGFR-3 can be seen in lymphatic vessels of the embryonic skin.The occurrences of VEGFR-3 protein in lymphatic vessels in E15 and in E21 were 38.71%(12/31) and 73.33%(22/30) respectively,the expression level of VEGFR-3 protein in E21 was significantly higher than that in E15(?~2=7.408,P
9.Neuroprotective effects of the effective components group of xiaoshuantongluo against oxygen-glucose deprivation in primary cultured rat cortical neurons.
Xinmei XIE ; Xiaobin PANG ; Yan ZHAO ; Baoquan WANG ; Ruoyun CHEN ; Guanhua DU
Acta Pharmaceutica Sinica 2014;49(8):1130-5
This study is to investigate the effect of the effective components group of Xiaoshuantongluo (XECG) on neuronal injury induced by oxygen-glucose deprivation (OGD) in primary cortical cultures isolated from SD rat cortex at day 3 and the possible mechanism. Cells were divided into control group, OGD model group and XECG group (1, 3 and 10 mg x L(-1)). The cell viability was assessed with MTT assay and the LDH release rate was measured by enzyme label kit. The cell apoptosis was analyzed using Hoechst staining. RT-PCR was applied to detect the mRNA levels of JAK2 and STAT3. Western blotting was used to detect the expressions of Bcl-2, Bax, p-JAK2 and p-STAT3 proteins. Results showed that XECG resulted in an obvious resistance to oxygen-glucose deprivation-induced cell apoptosis and decrement of cell viability, decrease the cell LDH release rate. XECG could adjust the expression of Bcl-2 and Bax proteins and increase Bcl-2/Bax ratio, up-regulate the expression of p-JAK2 and p-STAT3. In conclusion, XECG could protect against the neuronal injury cells exposed to OGD, which may be relevant to the promotion of JAK2/STAT3 signaling pathway, and impact the expression of Bax and Bcl-2.
10.The apoptosis induction on K562 cells by the CML bcr-abl gene antisense oligonucleotides
Juan PING ; Na ZHAO ; Baoquan WANG ; Zhihui SHEN ; Mingxing YIN ; Xiaobin PANG ; Chuanbo CHEN
China Oncology 2015;(3):167-172
Background and purpose:As the development of the completion of the human genome project (HGP), the research focus is turning to the gene function research. At present, the domestic experimental research on the apoptosis of K562 cells induced by antisense olignonucleotides is rare. This study was aimed to investigate the effect of human chronic myelogenou leukemia (CML) bcr-abl fusion gene antisense oligonucletides on autophagy and apoptosis of CMLK562 cells in vitro. Methods:By liposome as the carrier, K562 cells were transfected with the bcr-abl gene antisense olignonucleotides. Hoechst staining method was used to observe the apoptosis inducing effect of different concentrations of oligonucleotides, the expressions of LC3-Ⅱ, autophagy-related protein, were determined by the Western blot method, the cell cycles were determined by lfow cytometry (FCM), and JEM-4000EX electron microscope technology was used to detect the apoptosis morphological changes. The apoptosis was detected by DNA agarose gel electrophoresis. Results:Hoechst staining results showed that the bcr-abl gene antisense oligonucletides signiifcantly promoted the apoptosis of K562 cells in a certain concentration dependent manner. Western blot showed that the expression level of LC3-Ⅱwas obviously higher in bcr-abl gene antisense oligonucletides transfected group than the control group, showing a promoting effect on cell autophagy. FCM test results showed that bcr-abl gene antisense oligonucleotides transfected K562 cells showed obvious cell cycle arrest, visible obvious apoptosis morphology under the electron microscope, and DNA Ladder showed obvious apoptosis fragments. Conclusion:The bcr-abl gene antisense olignonucleotides can signiifcantly induce the cell apoptosis of K562. This study provides a new method for CML therapy.